Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$33,000.00

Transcriptional programmes downstream of the activated glucocorticoid receptor

FY 2020-21

Summary
BACKGROUND: This mechanism-based study is designed, by way of training high quality personnel (HQP), to characterise and promote understanding of the gene expression networks induced by the glucocorticoid receptor (GR/NR3C1). During stress, cortisol (a glucocorticoid) is produced by the adrenal cortex and is carried in the blood to target tissues. There, it acts on GR, a transcription factor that promotes breakdown of macromolecules to help maintain blood glucose during fasting and starvation. In infection and injury, glucocorticoids play a key survival role by reducing expression of mediators to dampen inflammation and promoting healing. Research, in my laboratory, focuses on how glucocorticoids act via GR to induce the expression of genes that are responsible for repressing inflammation. As lung epithelial cells are an important site of environmental insult and infection, they are used to model glucocorticoid-modulated gene expression. HYPOTHESIS: GR-dependent gene networks involve rapidly induced transcription factors that elicit distinct patterns of downstream gene expression and are responsible for physiological responses. AIMS: Prior characterisation of the global changes in gene expression in the human lung and in primary airway epithelial cells provides a list of the transcription factors most up-regulated by glucocorticoids. Three of the four mostly highly induced transcription factors; 1) KLF9, 2) PER1, and 3) ZBTB16 are selected for independent projects, each aiming to characterise mechanisms by which GR induces these factors and to establish their effect on downstream gene expression. EXPERIMENTAL APPROACHES: In the first part of each project, GR antagonists and gene silencing will test the GR-dependence of each induced factor in lung epithelial cells. The effects of each factor (KLF9, PER1, ZBTB15) on downstream gene expression will be tested by molecular approaches including gene over-expression and silencing followed by microarray analysis of gene expression to identify target genes. The ability of GR to bind control regions in the KLF9, PER1 and ZBTB16 genes will be assessed (by chromatin immunoprecipitation (ChIP)). Identified DNA binding sites will be assessed for functional ability to drive transcription. Likewise, the ability of GR and each of KLF9, PER1 and ZBTB16 to bind regulatory sites in downstream target genes will be evaluated. OUTCOMES: Within this programme of research, each independent project provides an ideal opportunity for the stepwise development of HQP. By characterising, the roles and downstream genes regulated by each transcriptional regulator, we map out a novel framework of transcriptional regulation by glucocorticoids in the airways. This advances core understanding of a fundamental human process, in particular the mechanisms underlying anti-inflammatory and other physiological effects of glucocorticoids.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-04549
Name nom
Newton, Robert
Department département
Cell Biology and Anatomy
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2016
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Installment
inst:5-6
Partie
2
Nb partie
6
Application title
Transcriptional programmes downstream of the activated glucocorticoid receptor
Keyword
NSERC
Application summary
BACKGROUND: This mechanism-based study is designed, by way of training high quality personnel (HQP), to characterise and promote understanding of the gene expression networks induced by the glucocorticoid receptor (GR/NR3C1). During stress, cortisol (a glucocorticoid) is produced by the adrenal cortex and is carried in the blood to target tissues. There, it acts on GR, a transcription factor that promotes breakdown of macromolecules to help maintain blood glucose during fasting and starvation. In infection and injury, glucocorticoids play a key survival role by reducing expression of mediators to dampen inflammation and promoting healing. Research, in my laboratory, focuses on how glucocorticoids act via GR to induce the expression of genes that are responsible for repressing inflammation. As lung epithelial cells are an important site of environmental insult and infection, they are used to model glucocorticoid-modulated gene expression. HYPOTHESIS: GR-dependent gene networks involve rapidly induced transcription factors that elicit distinct patterns of downstream gene expression and are responsible for physiological responses. AIMS: Prior characterisation of the global changes in gene expression in the human lung and in primary airway epithelial cells provides a list of the transcription factors most up-regulated by glucocorticoids. Three of the four mostly highly induced transcription factors; 1) KLF9, 2) PER1, and 3) ZBTB16 are selected for independent projects, each aiming to characterise mechanisms by which GR induces these factors and to establish their effect on downstream gene expression. EXPERIMENTAL APPROACHES: In the first part of each project, GR antagonists and gene silencing will test the GR-dependence of each induced factor in lung epithelial cells. The effects of each factor (KLF9, PER1, ZBTB15) on downstream gene expression will be tested by molecular approaches including gene over-expression and silencing followed by microarray analysis of gene expression to identify target genes. The ability of GR to bind control regions in the KLF9, PER1 and ZBTB16 genes will be assessed (by chromatin immunoprecipitation (ChIP)). Identified DNA binding sites will be assessed for functional ability to drive transcription. Likewise, the ability of GR and each of KLF9, PER1 and ZBTB16 to bind regulatory sites in downstream target genes will be evaluated. OUTCOMES: Within this programme of research, each independent project provides an ideal opportunity for the stepwise development of HQP. By characterising, the roles and downstream genes regulated by each transcriptional regulator, we map out a novel framework of transcriptional regulation by glucocorticoids in the airways. This advances core understanding of a fundamental human process, in particular the mechanisms underlying anti-inflammatory and other physiological effects of glucocorticoids.